| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $59.4B | $55.8B | $49.7B | $43.2B | $41.0B | $36.0B | $8.7B | $7.6B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $10.3B | $9.3B | $9.0B | $5.3B | $8.5B | $3.5B | $1.2B | $0.4B |
| EPS (Basic) | $25.93 | $22.94 | $21.97 | $12.66 | $19.41 | $7.82 | $2.59 | $0.77 |
| EPS (Diluted) | $25.68 | $22.70 | $21.80 | $12.55 | $19.27 | $7.79 | $2.57 | $0.76 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $272.3B | $246.5B | $230.7B | $199.1B | $200.1B | $190.8B | $176.9B | $167.8B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | $2.0B | $1.7B | $1.7B | $1.5B | $1.2B |
| Total Liabilities | $192.5B | $178.2B | $167.0B | $148.6B | $140.3B | $131.3B | $121.6B | $117.5B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $73.8B | $64.0B | $59.5B | $50.5B | $59.7B | $59.4B | $55.3B | $50.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $12.8B | $16.2B | $12.6B | $11.2B | $11.1B | $9.8B | $6.3B | — |
| Investing Cash Flow | $-11.3B | $-13.9B | $-7.6B | $-5.7B | $-6.7B | $-7.5B | $-5.9B | — |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-1.9B | $-2.2B | $-4.5B | $-5.1B | $-4.4B | $-2.1B | $-0.2B | — |